Delcath Systems Inc. (NASDAQ:DCTH)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for DCTH
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- champ: $DCTH - $1.56 - long ..looking for a break out around the $1.65 level....spec trade ..going to see if I can catch another leg up.
- steve71: $DCTH Delcath is a poorly managed company which has been killing investors for the last five years. They finally reported a good data set at ASCO. Using Dan's principle of "A lot of people just want to get their money back." I doubt there's much upside.
- champ: @steve71 - $DCTH - I hear you but I don't really care about this company...why would I ...I'm just in for a fast day trade.
- Tim S: Notable earnings after Wednesday's close $ADUS, $CPE, $DCTH, $DEPO, $EOX, $GERN, $HMIN, $IRET, $KKD, $MTDR, $MTN, $SGMS, $SUPN, WSM
- Tim S: Notable earnings after Wednesday's close $ACLS, $ACXM, $ALNY, $ALSK, $AMTG, $ANDE, $ATO, $ATVI, $AWAY, $AWK, $BALT, $BIOS, $BKD, $CBS, $CECO, $CKP, $CLR, $CODI, $CPE, $CTL, $CVG, $CXO, $CXW, $DCTH, $DGIT, $DK, $DVR, $DXCM, $ENS, $ERII, $EVC, $FLTX, $FTK, G, GA, $GNK, $HIMX, $HNSN, $HT, $INWK, $IO, $LPSN, $MAA, $MDLZ, $MKL, $MRIN, $NDLS, $NVTL, $OAS, OILT, $OSUR, $PDLI, $PHH, $PMT, $PMTC, $PRI, $PRU, $QCOM, $RIG, $RJET, $ROSE, $RST, $SCTY, $SLCA, $SN, $TCAP, $TEG, $TPX, $TS, $TSO, $TWTC, $UHAL, $WAC, WES, $WFM, $WG, WTI
- conner1012: $CELG They have a lot of catalysts that will continue to drive this north, not to mention some of which have been approved that should double their eps, supporting 120 to $130. MM-20 drug is looking good and could add 5 to 8$ per share. $9 to 12 per share in 2015 is very likely. Easily a $200 in my opinion. $DCTH continues to run!
- LarryD: $DCTH - I think this one is ready to break out. Is anybody following?
- jnag698: $DCTH - I'm long for the short term.
- Big D: $DCTH - @Larry nice action on Wednesday...I'll be looking to buy tomorrow on positive trading. dl
- conner1012: $DCTH breaking out, $2 in the next couple months. $CELG has MM-30 results that are not baked into the recent run, $125ish by May is my bet.
- markor01: $DCTH @Tricia....any opinion here? Looks good for next quarter?? Apologies if you already discussed as I haven't been in the forum much. Thanks in advance!
- MtChet: $DCTH - Bouncing off 50 DMA and breaking out of a #squeeze
- conner1012: $DCTH - buying some today. Interesting #squeeze with catalyst this year, won't hold through decision. Thank you CELG!
- conner1012: $DCTH took off filled everything but 300
- southern: Reuters reporting Irish Finance Minster says Ireland passes latest quarterly bailout review by ECB, $IMF and $EC officials ____________________________________ Early premarket gappers Gapping up: $DRWI +13.8%, $DCTH +4.4%, $MRK +4.3% Gapping down: $SVU -28.2%, $CALX -22.1%, PSLV -4.2%, $SAP -3.5%, $BHP -3.4%, DB -3.3%, $IMGN -3.2%, $BBL -2.7%, $RIO -2.4%, $HOLX -2.1%
-
moneytaker: ...
$DCTH,470600,118314,500715,2.36,2.46,2.50,2.57,-+-++,^vv^^,25
$AWR,276200,69480,131340,34.29,35.06,34.90,35.35,+++++,v^^^^,25
$DEI,2718800,684435,1258790,17.33,17.89,17.84,17.98,+++++,v^^^^,25
$DST,322000,81158,249962,45.96,47.45,47.45,47.51,--++ ... - tnt: $DCTH 20 day sma continues to hold as support
- tnt: $DCTH looks coiled to run on daily chart. Adding to swing long trade here. Near term target $5
- tnt: $DCTH setting up for upside out of this consolidation. Bollinger bands just starting to expand. Looking for a test of the 50 day ema and then $5 next significant resistance. Long DCTH
- tnt: $DCTH volume coming in, looks headed to mount $4
-
jververis: ...
New 52 week lows include: $ACW, $ADM, $ADVS, $AEIS, $AF, $AFAM, $AFL, $AGII, $AGO, $AIG, $AKAM, $AKS, $ALL, $ALNY, $ALR, $AMCC, $AMED, $AMKR, $AMSC, $ANAD, $ANR, $ANW, $AOL, $ARAY, $ARC, $ARI, $ARRY, $ART, $ASEI, $ASIA, $ATHX, ATPG, $AUO, $AUXL, $AV ... - tnt: $DCTH settling in here after the secondary. Could be a good time to start building a position
- tnt: $DCTH still showing 8.7 million shares sold short. This is their chance to cover, along with new longs coming in, should push the price higher
- joanie: $DCTH - I made a little on $DCTH in early July when the stock was popping for a few days, but I don't see any fundamental or technical reasons why the shorts should cover or longs should come in #RHRN.
- joanie: $DCTH - beasting on a VS expansion and it has a high short interest: 22% and 11 days to cover. I took a small position after it was already rolling at 6.27 but volume is really strong.
- tnt: $DCTH short #squeeze right now
- joanie: $DCTH - I'm channeling him today ;~) I told him a while back that i really liked that term because it captured momentum so well that I was likely to plagiarize it LOL
- tnt: $DCTH green in a nasty tape, Cowen assumes coverage on Delcath Systems (NASDAQ: DCTH) with an Outperform
- slowtime: $DNDN - tnt. I have place holder positions in the following biotechs: $ARIA, $AMRN, $CLDX, $DCTH,DNDN, HGSI,ONTY,$OPTR, $PCYC, and SPPI. I am long $IBB July 2011 puts, protection in case some or all of these stocks tank. I am 81% in cash. Am also short MOO. Would you be so kind to comment on these biotechs? Many thanks. @slowtime
- joanie: $DCTH - 23% short and it's up over 20% on approval of a hepatic delivery system in Europe. The shorts are scrambling as according to Finviz the short ratio is 9.85.
- slowtime: $DCTH - CallaLilly. The stock is up 4% at 10.48 on good vol of more than 1 million. I have a starter position from one month ago when you first mentioned it. Is there any news? Many thanks. @slowtime
- CallaLilly: $DCTH - I think its just getting closer to FDA NDA response. My mistake was ignoring the price action and focusing on @Adam Feurstein's evaluation, highly underinvested in something I really really believe in.
- CallaLilly: $DNDN - not in it at this moment because the easy money, oh yeah, all the way up to 58 and a nosedive has been made. It's fluctuations are too little against the upside for me. Why buy in now? There will be plenty of conferences and events to skim a ...
-
CallaLilly: ...
$DCTH seems to be getting tuckered out up in the 9's. Maybe it won't hit @Adam Feurstein's 7's but seems reasonable on a hard day to dip to the very low 8's.
$NKTR tired of waiting for the secondary to price, out and will reconsider,
- CallaLilly: $DCTH -http://stockcharts.com/h-sc/ui?s=DCTH&p=D&yr=1&mn=0&dy=0&id=p06497970838 ... not really sure what it's doing anymore. It's hit 8.70-8.83 several times and I want to own a bunch of this for ASCO in June. Started here and I guess will add much more over time in the 7's and under or with volume and strength as other traders start it over 9.30. Having last sold it around 14.00 and really thinking more good will come at ASCO. $CLDX - perplexed whilst waiting for the shelf to price. Another cancer vaccine company was bought yesterday and I have to ask why not CLDX.
-
CallaLilly: ...
$DCTH is a great biotech with a serious liver cancer candidate that ran on excitement last ASCO to 13 or 14, fell to (reality) 5ish and $BMR took it over 10. It's a truly great but @Adam Feurstein, not that he can perfectly price something but he is ... - CallaLilly: $DCTH - I'd love to have it in the 7's. This could/should/I want it to run into ASCO. Impatiently waiting for $CLDX to price its secondary to get more serious about this one. Along with $NKTR ... waiting to price to secondary and thinking if they want to do this one alone, I want to be there too.
- CallaLilly: $NKTR - biotech, initiated tracking position today at 11.56. Major downtrend which culminated today, or soon, due to a 19million share shelf. This should be the worst, or close to it.http://stockcharts.com/h-sc/ui?s=NKTR&p=D&b=5&g=0&id=p39003460919.The stock doubled last year on initial positive phase 1 results, the company has partnered on many products with $AMGN etc but this baby they want to do themselves, and that is pretty interesting. Will add when the secondary is over. $CLDX still waiting impatiently for the secondary to price. $DCTH ... waiting for a strong pullback.
-
CallaLilly: ...
Speaking of biotech the big deal coming beyond the usual is ASCO and who will shine. Some of these little ones will begin a run and many of those will do a shelf or have one already ready to pounce on the run up. It's I'm starting to make lists and ... - CallaLilly: Suzie - love it. Yes, researching many this week. Money is flowing. Still love $CLDX and $DCTH the most.
- CallaLilly: $VRTX -two arms of its trial stopped in '10; sure that this is not a good thing; this is not something I follow as I do $CLDX, $DCTH, DNDN. HGSI seemed like a sure blessed thing until the issue of less benefit in the second year and what does that r ...
- CallaLilly: Susie, what is a LEAPS portfolio? Yes, $VRTX is the main contender. Dreaming of more good updates on $CLDX and $DCTH at ASCO. The anecdotal evidence on $CLDX is extraordinary and yet $PFE (big dummy) dumped them. I love biotech ... which comes from the Latin word of life.
- CallaLilly: RCP - no, I wish. Liz is holding ... only holding/beginning pieces of $ACUR, $CLDX, $DCTH, HGSI, $PLX, $PTIE and a wee bit left of $ITMN (hoping for a major pullback).
-
CallaLilly: ...
$ITMN went waywardly up on major volume Friday ... the FDA event is sometime ahead of us and since the best target is 55. and most at 35. I sold with the expectation of a serious pullback. Biotech is weird ... and I think this and the $AMRN approval ... - steveingeneva: $DCTH - In the winners circle. Hardly pulled back this a.m. . Not crazy about the volume, but might make decent intemidiate term hold. Wait for pullback to 9.40 ish?
- eleKtra: UPS: Same place as where I bought it. $BIDU, up 2.2% today, my Dec #options up also. DGP also up 2% today (long long term) $AGQ up over 4% today (also long term) How did I miss TSLA? $DCTH up 3%. $GDXJ up 2.5% bought a few $NFLX #options, up 10% today, so far so good.
- tnt: $DCTH pushing higher out of month long bull flag consolidation here. Bollinger bands starting to expands. 19 days of short covering. Stochastics pushing higher ahead of move
- kellyt: $KNDI, $DCTH, $NXTM check out the charts on these. I'm in from lower levels but they are acting nicely. I took a shot at SNIC but was stopped out. I'll keep an eye on it though. Hope you all are doing great here in the forum! @Kelly
- tnt: $DCTH bull flag breakout today. Upcoming catalyst Thursday conference call. SHould have a nice run into the call
- tnt: $DCTH has gotten beaten silly the last few days. Starting to form a bull hammer today. Could have a nice sharp snapback rally from here. Long common
- charans: NDX--X : Hi Team NDX is showing some buying and strength as compare to others sp-500, dj-30, dj-20 etc.. May be some good buying there, along with Nat gas stocks which looks holding 2 days gains, bought some $CHK yesterday and looking to add more. $DCTH is still holding, the one stock I had bought around 12's, and full position in $AAPL ( half during flash crash and still holding).
- charans: NDX--X : Hi Team NDX is showing some buying and strength as compare to others sp-500, dj-30, dj-20 etc.. May be some good buying there, along with Nat gas stocks which looks holding 2 days gains, bought some $CHK yesterday and looking to add more. $DCTH is still holding, the one stock I had bought around 12's, and full position in $AAPL ( half during flash crash and still holding).
- taylor: $GOOG, $FAZ - A very strange market today. $GOOG and $FAZ are the only stocks on my $ST watch list that are green. I continue to hit singles in the option market: Sold $RMBS Jun 19 2010 15.0 Put @ 0.23 Sold $PII Jun 19 2010 50.0 Put @ 0.4 Sold $IOC Jun 19 2010 35.0 Put @ 0.6 Sold SMTS Jun 19 2010 22.5 Call @ 0.35 Sold $DCTH Jun 19 2010 21.0 Call @ 0.4 Sold $BP Jun 19 2010 46.0 Call @ 0.21 Sold $WMT Jul 17 2010 55.0 Call @ 0.21 Plus lightening up on one stock Sold $AUY @ 11.02
- HGIGuy: $DCTH - rebounding along 20 edma support line.
- Tim S: $DCTH - I jumped on this after hours ... Delcath has reported that its Phase $III clinical trial has met expectations Edited ... I bought at $12.05, and thought I was late to the game ... last trade was at $13.56
| Stock Price | $5.26 |
| Change | -3.49% |
| Volume | 146,954 |
Delcath Systems, Inc., is a pharmaceutical and medical device company. It focuses on the treatment of primary and metastatic liver cancers.
Request Video of DCTHAlready a member? Sign in here.
Past Month
Leading Peers
-
$6.71 34.55%
-
$75.03 9.46%
-
$8.00 4.74%
Past Month
Lagging Peers
-
$10.00 -24.14%
-
$10.40 -21.54%
-
$13.04 -21.51%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!